3.5 Mil. Doses Of Sanofi-Aventis’ Fluzone Still Unused, CDC Says
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS will wait to distribute GSK’s Fluarix until Fluzone supply is exhausted, Centers for Disease Control & Prevention Director Gerberding says. Some states have begun to relax recommendations so that people who are not in high priority groups can get vaccinated.
You may also be interested in...
Medicare Will Cover Flu Antivirals Under CMS Demonstration Project
The demo will allow CMS to collect data on how drug coverage affects beneficiaries’ health and costs ahead of the Medicare prescription drug benefit in 2006. Bristol’s Symmetrel, Forest’s Flumadine, Gilead’s Tamiflu and GlaxoSmithKline’s Relenza will be covered.
Medicare Will Cover Flu Antivirals Under CMS Demonstration Project
The demo will allow CMS to collect data on how drug coverage affects beneficiaries’ health and costs ahead of the Medicare prescription drug benefit in 2006. Bristol’s Symmetrel, Forest’s Flumadine, Gilead’s Tamiflu and GlaxoSmithKline’s Relenza will be covered.
GSK Flu Vaccine To Be Available In U.S. With Informed Consent
Patients using GSK's Fluarix under IND will need to complete an informed consent form. HHS is immediately purchasing 1.2 mil doses of the influenza vaccine, with an option to procure up to 2.8 mil. additional doses.